Chiamydia trachomatis is currently recognized as one of the most common sexually transmitted pathogens, with an expanding clinical spectrum which rivals that of gonococcal infections (10) . Because of the high prevalence of chlamydial infections there is a great need for sensitive and readily applicable procedures to diagnose these infections. The historic technique of demonstrating intracytoplasmic inclusions in Giemsa-stained conjunctival, urethral, or cervical scrapings was supplanted in the 1960s by yolk-sac isolation and shortly thereafter by tissue culture procedures. Because the tissue culture techniques are not readily available to many clinics, efforts have been made to refine assays of chlamydial antibodies as a means of diagnosing chlamydial infections.
The complement fixation (CF) test, a genusspecific test, has not been useful in diagnosing the localized genital tract infections (11) . The microimmunofluorescence (Micro-IF) test developed by Wang and Grayston has proven to be a sensitive and specific assay for antichlamydial antibodies (14) . Application of this test in selected cases (e.g., of men having a first attack of urethritis) has shown that it can be useful in diagnosing recently acquired chlamydial infection (1) . Unfortunately, the high prevalence of chlamydial antibodies in sexually active individuals has made it difficult to demonstrate changing antibody levels in paired acute-and convalescent-phase sera (8, 9) . Some workers have suggested that measurement of antibodies to chlamydiae in genital tract secretions might provide a useful diagnostic tool (2, 12 (6) (7) (8) . The 89% prevalence of chlamydial antibodies probably reflects cumulative exposure to these agents in a high-risk venereal disease population. It is unlikely that serological tests would be of greater benefit in diagnosing chlamydial infection in other populations. Women attending this clinic had a relatively high infection rate (20%) for chlamydiae, and the predictive value of a test increases with the prevalence of infection. Thus, these tests would not have a greater predictive value in populations having lower prevalence of infection unless the background rate of antibody decreased more than proportionately. Since it appears that chlamydial infection is common in sexually active populations, it is unlikely that FAILURE OF SEROLOGY IN CHLAMYDIAL INFECTIONS 649 this would prove to be the case in the populations most needing testing for chlamydial infections. In a study of female college students, McCormack and colleagues found a 4.6% prevalence of chlamydial infection, whereas only 13% of the total population had antibodies in their cervical secretions (5) . Here then is a lower-risk population with a lower rate of infection and a lower rate of cervical antibody than the one we studied (77% with IgG antibody). In these college women, the sensitivity and specificity of cervical secretion antibody would approach 90%, but as a function of the lower infection rate the predictive value of a positive test would still only be about 30%, similar to our findings. Other studies from the same laboratory indicated that in a more sexually experienced population, a 40% level of cervical antibody was found with only a 2% active infection rate (McCormack, personal communication) . From these results and other studies performed on tears in ocular chlamydial infections (4), it seems likely that antibodies in cervical secretions are essentially a reflection of circulating antibody. In our study, cervical IgG antibody was significantly associated (P < 0.001) with serum IgG antibody, since 73/74 (99%) of the women with cervical IgG antibody were also seropositive compared to 14/22 (64%) of cervical antibody-negative women. The same held true for IgM and IgA antibodies (data not shown).
It must be noted that statistically significant associations of chlamydial antibody with recovery of chlamydiae could be demonstrated for both cervical secretions (Table 1 ) and serum antibody, e.g., serum IgG antibodies could be associated with chlamydiae by increasing the dilution levels used to establish a positive result. However, there is a loss in the sensitivity of the test as the specificity is increased by more rigorous criteria. Although antibodies could be associated, in a statistical sense, with the presence of the organism, the ultimate utility of a serological test is its predictive value (probability that a positive test indicates infection) (3) . Given the 20% prevalence rate, one could randomly choose one in five women in this clinic as having a chlamydial infection; if the entire battery of serological tests were added, the best result would not increase the chances of correctly identifying a chlamydial-infected woman to one in three. It seems unlikely that these tests can be used for diagnosing chlamydial infections (or even as a screening test for them except in highly selected populations).
In our opinion, the only currently available useful test is direct isolation of the agent. Sensitivity of tissue culture isolation procedures is not known, but based on the results of repeated screening tests it is probably 80 to 90%. However, isolating the agent diagnoses infection and has a predictive value of 100%. Since chlamydial infections are highly prevalent, can be treated, and are associated with significant morbidity, it would seem that addition of chlamydial isolation capabilities is warranted in any major medical facility treating patients who have sexually transmitted diseases.
